Jaffna Teaching Hospital
Jaffna, Sri Lanka
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences96 enrolled50 locationsNCT06466135
Recruiting
Phase 3
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Type 2 Diabetes
The George Institute994 enrolled8 locationsNCT05345327